Sitravatinib
Sitravatinib Uses, Dosage, Side Effects, Food Interaction and all others data.
Sitravatinib is under investigation in clinical trial NCT03680521 (Neoadjuvant Sitravatinib in Combination With Nivolumab in Patients With Clear Cell Renal Cell Carcinoma).
| Trade Name | Sitravatinib |
| Generic | Sitravatinib |
| Sitravatinib Other Names | Sitravatinib |
| Type | |
| Formula | C33H29F2N5O4S |
| Weight | Average: 629.68 Monoisotopic: 629.190831934 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Sitravatinib
